Loading...

IDSA Statements

Bad Bugs, No Drugs, No ESKAPE: An Update by IDSA (the state of the antibiotic pipeline); Boucher et al  01/01/2009

IDSA Report on Development Pipeline • CID 2009:48 (1 January) • 1 I D S A R E P O R T Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America Helen W. Boucher,1 George H. Talbot,2 John S. Bradley,3,4 John E. Edwards, Jr,5,6,7 David Gilbert,8 Louis B. Rice,9,10 Michael Scheld,11 Brad Spe

 
IDSA Testimony on Antimicrobial Resistance at FDA Part 15 Hearing  04/28/2008
IDSA presented testimony to a US Food and Drug Administration (FDA) panel on April 28 to address the increasingly troublesome issue of antimicrobial resistance.
 
The Epidemic of Antimicrobial Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America January 15, 2008  12/12/2007

Published in Clinical Infectious Diseases [CID 2008:46 (15 January)].

 
Principles and Strategies to Limit Impact of Antimicrobial Resistance  05/22/2006

IDSA Principles and Strategies Intended to Limit the Impact of Antimicrobial Resistance.

 
Project Bioshield Reathorization  04/06/2006

Statement from Martin J. Blaser, MD, IDSA's President

 
IDSA Opposes Stifling Small Business Admin. Action Affecting Biotech and Device R&D  11/08/2005

Building on its "Bad Bugs, No Drugs" effort, IDSA works with coalition to support legislative fix.

 
Infectious Diseases Experts Back Bill to Fight Bad Bugs  04/27/2005

Infectious diseases experts are applauding the introduction of the “Project Bioshield II Act of of 2005,” a bill that is designed to better protect the nation against the growing threats of antibiotic-resistant infections and pandemic influenza, as well as bioterrorism and emerging infections.

 
Project Bioshield Statement before the Committee on Government Reform  04/04/2003

Statement of the Infectious Diseases Society of America (IDSA) concerning “Project Bioshield” Presented by John E. Edwards, MD Before the Committee on Government Reform U.S. House of Representatives April 4, 2003

 




Loading...